162 related articles for article (PubMed ID: 10887042)
1. Antiplatelet and antithrombotic effect of D-003.
Molina V; Arruzazabala ML; Carbajal D; Más R; Valdés S
Pharmacol Res; 2000 Aug; 42(2):137-43. PubMed ID: 10887042
[TBL] [Abstract][Full Text] [Related]
2. Effect of D-003 on intravascular platelet aggregation induced with collagen in rats.
Molina V; Carbajal D; Arruzazabala L; Más R
J Med Food; 2005; 8(2):232-6. PubMed ID: 16117616
[TBL] [Abstract][Full Text] [Related]
3. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites.
Molina V; Arruzazabala ML; Carbajal D; Más R
Prostaglandins Leukot Essent Fatty Acids; 2002 Jul; 67(1):19-24. PubMed ID: 12213431
[TBL] [Abstract][Full Text] [Related]
4. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
5. Effects of D-003, a mixture of very long chain fatty acids purified from sugar cane wax, at 5 and 10 mg/day on platelet aggregation in healthy volunteers.
Arruzazabala ML; Molina V; Carbajal D; Fernández L; Mas R; Castaño G; Illnait J; Mendoza S; Fernańdez J
Int J Clin Pharmacol Res; 2005; 25(1):29-39. PubMed ID: 15868655
[TBL] [Abstract][Full Text] [Related]
6. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
Cook NS; Bruttger O; Pally C; Hagenbach A
Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
[TBL] [Abstract][Full Text] [Related]
7. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
Ogawa T; Sugidachi A; Naganuma H; Asai F
Thromb Res; 2000 Mar; 97(5):307-15. PubMed ID: 10709906
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and antiplatelet activities of Korean red ginseng extract.
Jin YR; Yu JY; Lee JJ; You SH; Chung JH; Noh JY; Im JH; Han XH; Kim TJ; Shin KS; Wee JJ; Yun YP
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):170-5. PubMed ID: 17309520
[TBL] [Abstract][Full Text] [Related]
11. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
[TBL] [Abstract][Full Text] [Related]
14. Extract of Ulmus macrocarpa Hance prevents thrombus formation through antiplatelet activity.
Yang WK; Lee JJ; Sung YY; Kim DS; Myung CS; Kim HK
Mol Med Rep; 2013 Sep; 8(3):726-30. PubMed ID: 23846328
[TBL] [Abstract][Full Text] [Related]
15. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
[TBL] [Abstract][Full Text] [Related]
17. An ethanol extract of Ramulus mori improves blood circulation by inhibiting platelet aggregation.
Lee J; Kwon G; Park J; Kim JK; Choe SY; Seo Y; Lim YH
Biosci Biotechnol Biochem; 2016 Jul; 80(7):1410-5. PubMed ID: 26967156
[TBL] [Abstract][Full Text] [Related]
18. Effect of vintoperol on platelet aggregation and experimental thrombosis.
Csomor K; Kárpáti E
Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats.
Peng Y; Zeng X; Feng Y; Wang X
J Cardiovasc Pharmacol; 2004 Jun; 43(6):876-81. PubMed ID: 15167282
[TBL] [Abstract][Full Text] [Related]
20. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
